Sign In
Buy HCAT
$1.33
-0.0200 (-1.48%)
At Close: Jun 03, 2026
SunTrust Robinson Sticks to Its Buy Rating for Health Catalyst (HCAT)
06:53pm, Wednesday, 22'nd Apr 2020
SunTrust Robinson analyst Sandy Draper maintained a Buy rating on Health Catalyst (HCAT) today and set a price target of $30.00. The company's shares
SunTrust Robinson Sticks to Its Buy Rating for Health Catalyst (HCAT)
06:53pm, Wednesday, 22'nd Apr 2020
SunTrust Robinson analyst
Sandy Draper
maintained a
Buy
rating on Health Catalyst (
HCAT
–
Research Report
) today and set a price target of
$30.00
. The company’s shares closed last Wednesday at
Health Catalyst (HCAT) Receives a Buy from Cantor Fitzgerald
06:52pm, Wednesday, 22'nd Apr 2020
In a report issued on April 20, Steven Halper from Cantor Fitzgerald reiterated a Buy rating on Health Catalyst (HCAT), with a price target of $44.00. The
Health Catalyst (HCAT) Receives a Buy from Cantor Fitzgerald
06:52pm, Wednesday, 22'nd Apr 2020
In a report issued on April 20, Steven Halper from Cantor Fitzgerald reiterated a Buy rating on Health Catalyst (HCAT
Health Catalyst (HCAT) Receives a Buy from RBC Capital
03:56pm, Wednesday, 22'nd Apr 2020
In a report issued on April 20, Sean Dodge from RBC Capital maintained a Buy rating on Health Catalyst (HCAT), with a price target of $30.00. The
Health Catalyst (HCAT) Receives a Buy from RBC Capital
03:56pm, Wednesday, 22'nd Apr 2020
In a report issued on April 20, Sean Dodge from RBC Capital maintained a Buy rating on Health Catalyst (HCAT
UBS softens view on Eli Lilly in premarket analyst action
11:14am, Tuesday, 21'st Apr 2020
Allscripts Healthcare Solutions (NASDAQ:MDRX) initiated with an Outperform rating and an $8 (21% upside) price target at RBC.Aprea Therapeutics (NASDAQ:APRE) initiated with an Outperform rating and a
Health Catalyst National Data Repository Helps Clients Battle COVID-19
12:24pm, Monday, 20'th Apr 2020
Healthcare providers and public health authorities across the country are struggling to answer complex questions related to the COVID-19 pandemic. Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCA
Health Catalyst and Carle Health Partner to Improve Patient Care with Data and Analytics Solutions
12:00pm, Tuesday, 14'th Apr 2020
Carle Health today joined Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, in announcing a five ye
Leerink rolls out lineup of bullish calls in premarket analyst action
11:51am, Monday, 13'th Apr 2020
Allogene Therapeutics (NASDAQ:ALLO) initiated with Buy rating and $29 (28% upside) price target at SunTrust.Allscripts Healthcare Solutions (NASDAQ:MDRX) initiated with Market Perform rating and $8 (1
Health Catalyst (HCAT) Gets a Buy Rating from Canaccord Genuity
10:06am, Monday, 13'th Apr 2020
In a report issued on April 9, Richard Close from Canaccord Genuity maintained a Buy rating on Health Catalyst (HCAT), with a price target of $40.00. The
Health Catalyst (HCAT) Gets a Buy Rating from Canaccord Genuity
10:05am, Monday, 13'th Apr 2020
In a report issued on April 9, Richard Close from Canaccord Genuity maintained a Buy rating on Health Catalyst (HCAT
Health Catalyst, Inc. Prices Upsized Offering of $200 Million 2.50% Convertible Senior Notes Due 2025
04:34am, Thursday, 09'th Apr 2020
Health Catalyst, Inc. (HCAT) (the “Company” or “Health Catalyst”) announced today the pricing of $200.0 million aggregate principal amount of 2.50% convertible senior notes due 2025 (the “n
